Erectile dysfunction management after failed phosphodiesterase-5-inhibitor trial: a cost-effectiveness analysis

BACKGROUND: To evaluate the cost-effectiveness of alternate erectile dysfunction (ED) management options after failed first line phosphodiesterase-5-inhibitors (PDE5-I). METHODS: An empiric, repetitive decision tree analysis model was constructed using literature review and expert clinical judgement...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Transl Androl Urol
Main Authors: Moses, Rachel A., Anderson, Ross E., Kim, Jaewhan, Keihani, Sorena, Craig, James R., Myers, Jeremy B., Lenherr, Sara M., Brant, William O., Hotaling, James M.
Formato: Artigo
Idioma:Inglês
Publicado em: AME Publishing Company 2019
Assuntos:
Original Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6732088/
https://ncbi.nlm.nih.gov/pubmed/31555563
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.21037/tau.2019.03.10
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados